Skip to content

Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis

Non Interventional Clinical Investigation of Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02669446
Enrollment
90
Registered
2016-02-01
Start date
2016-01-31
Completion date
2016-06-30
Last updated
2016-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Viral Pharyngitis

Keywords

Non interventional study, Ectoin, Lozenges, pharyngitis

Brief summary

This a comparative, open label, parallel group, non interventional study which compares the tolerability and influence of Ectoin containing Lozenges to saline solution and lozenges containing hyaluronic acid for the treatment of acute viral Pharyngitis. The observation takes place over a period of 7 days. Response to treatment is recorded at day 1 and day 7 by the physician and by the patient in a dairy.

Interventions

DEVICEMedical devices
DEVICEtraditional household remedy

Sponsors

Bitop AG
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with acute Pharyngitis according to instruction for use * Female or male individuals ≥ 18 years * Agreement to abide by the routinely provided doctor's appointment for follow- up (reflected in the planned visits of observation plan resist)

Exclusion criteria

* Contraindications according to instructions for use * Male or female person under 18 years * Sore throat for more than 5 days * Any disease that can, in the opinion of the treating physician to affect the outcome of the study. * Patients with known intolerance to one of the substances used * Surgical procedures to the mouth and throat in the last 6 weeks before inclusion in the NIS * Bacterial Pharyngitis * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Pharyngitis symptom score evaluated by the physicianday 1 and day 7The intensity of the symptoms and signs will be graded on a continuous numeric scale, i.e. absent-0, severe-10. The following signs and symptoms will be documented: * pain on swallowing * tickle in the throat * hoarseness * dry mouth and throat * burning of throat * patient´s General condition * reddening of the oropharynx * reddening of the larynx

Secondary

MeasureTime frameDescription
Change in Pharyngitis symptoms evaluated on patient´s diaries7 daysThe intensity of the symptoms and signs will be graded on a continuous numeric scale, i.e. absent-0, severe-10. The following signs and symptoms will be documented: * pain on swallowing * tickle in the throat * hoarseness * dry mouth and throat * burning of throat * patient´s General condition
Change in patient´s General condition evaluated by the physicianday 1 and day 7
Patient´s Evaluation of tolerability7 daysAssessment of tolerability on a numeric scale (bad-0; very good-10)
physician´s Evaluation of tolerabilityday 7Assessment of tolerability on a numeric scale (bad-0; very good-10)
Change in number and type of adverse Events7 daysIncidence of adverse Events and correlations with the therapy

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026